-DOCSTART- -X- O
Neutralizing -X- _ O
antibodies -X- _ O
play -X- _ O
an -X- _ O
essential -X- _ O
part -X- _ O
in -X- _ O
antiviral -X- _ O
immunity -X- _ O
and -X- _ O
are -X- _ O
instrumental -X- _ O
in -X- _ O
preventing -X- _ O
or -X- _ O
modulating -X- _ O
viral -X- _ O
diseases. -X- _ O
Polyclonal -X- _ O
antibody -X- _ O
preparations -X- _ O
are -X- _ O
increasingly -X- _ O
being -X- _ O
replaced -X- _ O
by -X- _ O
highly -X- _ O
potent -X- _ B-Intervention
monoclonal -X- _ I-Intervention
antibodies -X- _ I-Intervention
( -X- _ I-Intervention
mAbs -X- _ I-Intervention
) -X- _ I-Intervention
. -X- _ O
Cocktails -X- _ B-Outcome
of -X- _ I-Outcome
mAbs -X- _ I-Outcome
and -X- _ I-Outcome
bispecific -X- _ I-Outcome
constructs -X- _ I-Outcome
can -X- _ I-Outcome
be -X- _ I-Outcome
used -X- _ I-Outcome
to -X- _ I-Outcome
simultaneously -X- _ I-Outcome
target -X- _ I-Outcome
multiple -X- _ I-Outcome
viral -X- _ I-Outcome
epitopes -X- _ I-Outcome
and -X- _ I-Outcome
to -X- _ I-Outcome
overcome -X- _ I-Outcome
issues -X- _ I-Outcome
of -X- _ I-Outcome
neutralization -X- _ I-Outcome
escape. -X- _ I-Outcome
Advances -X- _ O
in -X- _ O
antibody -X- _ O
engineering -X- _ O
have -X- _ O
led -X- _ O
to -X- _ O
a -X- _ O
large -X- _ O
array -X- _ O
of -X- _ O
novel -X- _ O
mAb -X- _ O
formats -X- _ O
, -X- _ O
while -X- _ O
deeper -X- _ O
insight -X- _ O
into -X- _ O
the -X- _ O
biology -X- _ O
of -X- _ O
several -X- _ O
viruses -X- _ O
and -X- _ O
increasing -X- _ O
knowledge -X- _ O
of -X- _ O
their -X- _ O
neutralizing -X- _ O
epitopes -X- _ O
has -X- _ O
extended -X- _ O
the -X- _ O
list -X- _ O
of -X- _ O
potential -X- _ O
targets. -X- _ O
In -X- _ O
addition -X- _ O
, -X- _ O
progress -X- _ B-Outcome
in -X- _ I-Outcome
developing -X- _ I-Outcome
inexpensive -X- _ I-Outcome
production -X- _ I-Outcome
platforms -X- _ I-Outcome
will -X- _ I-Outcome
make -X- _ I-Outcome
antiviral -X- _ I-Outcome
mAbs -X- _ I-Outcome
more -X- _ I-Outcome
widely -X- _ I-Outcome
available -X- _ I-Outcome
and -X- _ I-Outcome
affordable -X- _ I-Outcome
. -X- _ O

